Prevalence and Treatment Patterns of Pelvic Health Disorders Among U.S. Women. The Lewin Group. 2007.

Menorrhagia. eMedicine.com. May 2005. EMedicine web site. http://www.emedicine.com. Accessed Sept. 21, 2005.

Moalli PA, Jones IS, Meyn LA, Zyczynski HM. Risk factors associated with pelvic floor disorders in women undergoing surgical repair. Obstet Gynecol 2003;101(5 Pt 1):869-874.

Shaw JA. Menorrhagia. January 12, 2007. Emedicine web site. http://www.emedicine.com. Accessed May 19, 2007.

Lethaby A, Vollenhoven B. Fibroids (uterine myomatosis, leiomyomas). Am Fam Physician. 2005 May 1;71(9):1753-6.

Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril. 2007 Apr;87(4):725-36.

Marino JA, et al. Uterine leiomyoma and menstrual cycle characteristics in a population-based cohort study. Hum Reprod. 2004 Oct;19(10):2350-5. Epub 2004 Jul 8.

Anders K. Recent developments in stress urinary incontinence in women. Nurs Stand. May 10-16 2006;20(35):48-54.

Deutchman M. Stress urinary incontinence in women: Diagnosis and medical management. December 2005. Medscape web site. http://www.medscape.com. Accessed May 17, 2007.

Swift S, Woodman P, O'Boyle A, et al. Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. Am J Obstet Gynecol 2005;192(3):795-806.

Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A. Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. Am J Obstet Gynecol 2002;186(6):1160-1166.

Jelovsek JE, Barber MD. Women seeking treatment for advanced pelvic organ prolapse have decreased body image and quality of life. Am J Obstet Gynecol. 2006 May;194(5):1455-61.

Burrows LJ, Meyn LA, Walters MD, Weber AM. Pelvic symptoms in women with pelvic organ prolapse. Obstet Gynecol. 2004 Nov;104(5 Pt 1):982-8.

Cohen JD, Rubin HW. Functional menorrhagia: treatment with bioflavonoids and vitamin C. Curr Ther Res 1960;2:539-4.

Ziaei S, Zakeri M, Kazemnejad A. A randomized controlled trial of vitamin E in the treatment of primary dysmenorrheal. BJOG. 2005;112:466-469.

Taymor ML, Sturgis SH, Yahia C. The etiological role of chronic iron deficiency in production of menorrhagia. JAMA 1964;187:323-7.

Samuels, AJ. Studies in patients with functional menorrhagia: the antimenorrhagic effect of the adequate replication of iron stores. Isr J Med Sci 1965;1:851-3.

Shaw RW. Assessment of medical treatments for menorrhagia. Br J Obstet Gynaecol. 1994 Jul;101 Suppl 11:15-8.

Fraser IS, McCarron G. Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia. Aust N Z J Obstet Gynaecol. 1991 Feb;31(1):66-70.

Prentice A. Fortnightly review. Medical management of menorrhagia. BMJ. 1999 Nov 20;319(7221):1343-5.

Marjoribanks J, Lethaby A, Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev. 2003;(2):CD003855.

Protheroe J. Modern management of menorrhagia. J Fam Plann Reprod Health Care. 2004 Apr;30(2):118-22.

Bongers MY, Mol BW, Brolmann HA. Current treatment of dysfunctional uterine bleeding. Maturitas. 2004 Mar 15;47(3):159-74.

David-Montefiore E, Rouzier R, Chapron C, Darai E. Surgical routes and complications of hysterectomy for benign disorders: a prospective observational study in French university hospitals. Hum Reprod. 2007 Jan;22(1):260-5.

Makinen J, Johansson J, Tomas C, et al. Morbidity of 10 110 hysterectomies by type of approach. Hum Reprod. 2001 Jul;16(7):1473-8.

Friedman AJ, Lobel SM, Rein MS, Barbieri RL. Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis. Am J Obstet Gynecol. 1990 Oct;163(4 Pt 1):1114-9.

Pron G, Bennett J, Common A, et al. Ontario Uterine Fibroid Embolization Collaboration Group. The Ontario Uterine Fibroid Embolization Trial. Part 2. Uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids. Fertil Steril. 2003 Jan;79(1):120-7.

Pron G, Mocarski E, Bennett J, Vilos G, et al. Ontario UFE Collaborative Group. Pregnancy after uterine artery embolization for leiomyomata: the Ontario multicenter trial. Obstet Gynecol. 2005 Jan;105(1):67-76.

Stewart EA, Rabinovici J, Tempany CM, et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril. 2006 Jan;85(1):22-9.

Comino R, Torrejon R. Hysterectomy after endometrial ablation-resection.

J Am Assoc Gynecol Laparosc. 2004 Nov;11(4):495-9.

Matchar DB, Myers ER, Barber MW et al. Management of uterine fibroids. Evid Rep Technol Assess (Summ). 2001 Jan;(34):1-6.

Hutchins FL Jr. Myomectomy after selective preoperative treatment with a gonadotropin releasing hormone analogue. 1992. J Reprod Med 37:699.

Doridot V, Dubuisson JB, Chapron C, Fauconnier A, Babaki-Fard K.J Recurrence of leiomyomata after laparoscopic myomectomy.Am Assoc Gynecol Laparosc. 2001 Nov;8(4):495-500.

Ghoniem GM, Van Leeuwen JS, Elser DM, Freeman RM, Zhao YD, Yalcin I, Bump RC; Duloxetine/Pelvic Floor Muscle Training Clinical Trial Group. A randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence. J Urol. 2005 May;173(5):1647-53.

Albo ME, Richter HE, Brubaker L, et al. Burch Colposuspension versus Fascial Sling to Reduce Urinary Stress Incontinence. N Engl J Med. 2007 May 21;

ACOG Technical Bulletin: Pelvic Organ Prolapse. BJOG 1995;52:197-205.

Weber AM, Richter HE. Pelvic organ prolapse. Obstet Gynecol; 2005;106(3):615-634.